Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

Ann: Scheme Booklet registered with ASIC, page-127

First 127 Last

Share
Profile

Follow
Arrowhead

642 Posts.

87

21/07/22

16:41

Post #: 62658466
Share
Originally posted by TerribleTadpole: ↑

These opinions need to be considered carefully. From my perspective I plan to vote no and deal with the fallout, but these facts need to be acknowledged:
ResApp's bank account is basically empty. The Scheme Booklet states that the company has spend all of its own working capital on the takeover. The funds contributed by Pfizer are probably already mostly spent, and any balance is earmarked for the Covid-19 test, not funding continuing operations.
If the takeover fails there will definitely be a sudden rush for the exit.
Therefore the company will have to raise capital pretty much instantly if the takeover fails.
The only three options are: a) go to the financial institutions at a discount to whatever the share price is at the time, b) find an ethical investor(s) prepared to pay a premium on humanitarian or scientific grounds, c) wind up.

Personally I'm in favour of pushing through, re-funding, and working on the company's core business case:
The most significant technological advance in acoustic respiratory diagnosis since the invention of the stethoscope.
A suite of clinically proven, stable, diagnostic targets that includes some of the most serious debilitating and lethal respiratory conditions.
A remote-diagnosis tool perfectly aligned with current market conditions of limited patient appetite for attending crowded clinics in person.
An opportunity to deploy a lifeline to the most downtrodden and vulnerable groups in the world, no matter where they are.
A foundation that can have additional conditions added over time. Covid-19 is one such condition, it's a pity that we have allowed a potential accessory to the core product eclipse the entire operation.

Those of you who are not able to bear possibility of a slump should consider ways to deal with that risk.

I'd also like to see a considerable improvement in the company's risk management and contingency planning in the future.

Expand

Originally posted by AlCp: ↑

Your "per se" more than likely mean the market lumped EPY into this BNPL sector anyway. It's just smart strategy for a global giant to offer the low end and up this to the recommended price than start at the recommended price and up this to the high end.

This give them the option if they want to make certain of a YES vote, they will up the bid to 27c after the NO vote since this would be a good strategy to use for the holders who didn't initial consider the YES vote even at 27c.

Expand

Would TT take 27c though? Based on his last post it would appear not as he has indicated non-financial motivation for his investment.
RAP Price at posting: 12.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

MCT

Metalicity looking for offers on Admiral Bay zinc project

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

Talking Australia's very competitive property landscape: Realty Talks

AI stocks: What to expect in 2024-25

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

There are more pages in this discussion • 25 more messages in this thread...

First 127 Last

Add RAP (ASX) to my watchlist